Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Masao, Sekiyama"'
Autor:
Masao Sekiyama, Yoshikazu Hara, Shinya Suzuki, Junichi Kusano, Rei Kato, Yoshiaki Fujii, Hiroto Matsuda, Kentaro Sugiyama, Toshihiko Hirano, Eiki Ando
Publikováno v:
Therapeutic Apheresis and Dialysis. 21:270-278
The ATP monitoring assay is a useful biomarker for risk monitoring to detect infection and rejection episodes in transplant recipients. Hemodialysis patients have a higher rate of infectious mortality. Infections in hemodialysis patients are mainly c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5e1230a1608f03b8a8305dbf83e896a
https://doi.org/10.1111/1744-9987.12513
https://doi.org/10.1111/1744-9987.12513
Autor:
Sachiko Tanaka, Junichi Kusano, Yoshiaki Fujii, Kentaro Sugiyama, Hiroto Matsuda, Masao Sekiyama, Shinya Suzuki, Yoshikazu Hara, Toshihiko Hirano, Eiki Ando
Publikováno v:
Journal of clinical pharmacy and therapeutics. 43(6)
What is known and objective Renal transplant recipients receive immunosuppressive therapy to prevent acute rejection. We evaluated the immunopharmacological efficacy of vitamin K1 (VK1) and vitamin K2 (VK2) on T-cell mitogen-activated-peripheral lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2861ab3ad54ff78d64a15c9ff814f25
https://pubmed.ncbi.nlm.nih.gov/30014604
https://pubmed.ncbi.nlm.nih.gov/30014604
Autor:
Junichi, Kusano, Rei, Kato, Hiroto, Matsuda, Yoshikazu, Hara, Yoshiaki, Fujii, Shinya, Suzuki, Masao, Sekiyama, Eiki, Ando, Kentaro, Sugiyama, Toshihiko, Hirano
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 21(3)
The ATP monitoring assay is a useful biomarker for risk monitoring to detect infection and rejection episodes in transplant recipients. Hemodialysis patients have a higher rate of infectious mortality. Infections in hemodialysis patients are mainly c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::513a6ffc159b713c9feddf89e2aa6f2a
https://pubmed.ncbi.nlm.nih.gov/28296195
https://pubmed.ncbi.nlm.nih.gov/28296195
Autor:
Hitoshi Sato, Erika Sugiyama, Vilasinee Hirunpanich, Masao Sekiyama, Kiyomi Saito, Yuka Murayama, Shinya Suzuki
Publikováno v:
YAKUGAKU ZASSHI. 130:613-620
We established a method for estimating pediatric doses of drugs metabolized by cytochrome P450 (CYP) isozymes, using the free fraction of drug in plasma (fu), serum protein level (P), liver volume (LV), and CYP activity (Vmax/Km) as indices of physio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7411eedd91d8645779046404139e37a
https://doi.org/10.1248/yakushi.130.613
https://doi.org/10.1248/yakushi.130.613
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36:763-767
The aim of the present study was to derive an equation for estimating doses of renal-excretion drugs in neonates based on clearance ratios for neonates and adults as well as in consideration of postconceptional age (PCA).The following equation was de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07b3f8048159c1300dda50a77432be66
https://doi.org/10.5649/jjphcs.36.763
https://doi.org/10.5649/jjphcs.36.763
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35:791-798
We investigated the pediatric doses of drugs for children aged 2 years to less than 15 years for the following age groups : early childhood (2-5 years),childhood (6-11 years),and puberty (12-14 years).Pediatric dosages indicated in package inserts of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a04f0f11db9fd403d01858f70958299c
https://doi.org/10.5649/jjphcs.35.791
https://doi.org/10.5649/jjphcs.35.791
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 129(7)
We established dose estimation formulae for renal-excretion drugs using the glomerular filtration rate (GFR), tubular secretion clearance (Sc), and unbound fraction of drug in plasma (fp) as a renal function index of physiological development in neon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c64496a18f87e709a6ceeebfdc9cb00
https://pubmed.ncbi.nlm.nih.gov/19571518
https://pubmed.ncbi.nlm.nih.gov/19571518